These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 27074913)

  • 1. Structure, function, and genetics of lipoprotein (a).
    Schmidt K; Noureen A; Kronenberg F; Utermann G
    J Lipid Res; 2016 Aug; 57(8):1339-59. PubMed ID: 27074913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a): resurrected by genetics.
    Kronenberg F; Utermann G
    J Intern Med; 2013 Jan; 273(1):6-30. PubMed ID: 22998429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases.
    Kronenberg F
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):87-100. PubMed ID: 26896185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region.
    Kronenberg F
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):5-12. PubMed ID: 30859385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a): more interesting than ever after 50 years.
    Dubé JB; Boffa MB; Hegele RA; Koschinsky ML
    Curr Opin Lipidol; 2012 Apr; 23(2):133-40. PubMed ID: 22327610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction.
    Enas EA; Varkey B; Dharmarajan TS; Pare G; Bahl VK
    Indian Heart J; 2019; 71(2):99-112. PubMed ID: 31280836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a): an important cardiovascular risk factor and a clinical conundrum.
    Koschinsky ML; Boffa MB
    Endocrinol Metab Clin North Am; 2014 Dec; 43(4):949-62. PubMed ID: 25432390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.
    Nordestgaard BG; Langsted A
    J Lipid Res; 2016 Nov; 57(11):1953-1975. PubMed ID: 27677946
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Mu-Han-Ha-Li 迪丽达尔 木汗哈力 DL; Zhai 翟天羽 TY; Ling 凌雁 Y; Gao 高鑫 X
    J Lipid Res; 2018 May; 59(5):884-891. PubMed ID: 29511049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis.
    Lamina C; Kronenberg F;
    JAMA Cardiol; 2019 Jun; 4(6):575-579. PubMed ID: 31017618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
    Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
    BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus.
    Sankaranarayanan K; Chakraborty R; Boerwinkle EA
    Mutat Res; 1999 Jan; 436(1):21-57. PubMed ID: 9878681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.
    Lu W; Cheng YC; Chen K; Wang H; Gerhard GS; Still CD; Chu X; Yang R; Parihar A; O'Connell JR; Pollin TI; Angles-Cano E; Quon MJ; Mitchell BD; Shuldiner AR; Fu M
    Hum Mol Genet; 2015 Apr; 24(8):2390-400. PubMed ID: 25575512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical evaluation of the role of Lp(a) in cardiovascular disease: can Lp(a) be useful in risk assessment?
    Marcovina SM; Koschinsky ML
    Semin Vasc Med; 2002 Aug; 2(3):335-44. PubMed ID: 16222623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
    Boffa MB; Koschinsky ML
    J Lipid Res; 2016 May; 57(5):745-57. PubMed ID: 26647358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies.
    Tsimikas S
    J Am Coll Cardiol; 2017 Feb; 69(6):692-711. PubMed ID: 28183512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a): a causal independent risk factor for coronary heart disease?
    Gudnason V
    Curr Opin Cardiol; 2009 Sep; 24(5):490-5. PubMed ID: 19623058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress in lipoprotein (a): aspects of biochemistry and molecular biology].
    Huang YT
    Sheng Li Ke Xue Jin Zhan; 1996 Jan; 27(1):25-30. PubMed ID: 8731979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
    Gudbjartsson DF; Thorgeirsson G; Sulem P; Helgadottir A; Gylfason A; Saemundsdottir J; Bjornsson E; Norddahl GL; Jonasdottir A; Jonasdottir A; Eggertsson HP; Gretarsdottir S; Thorleifsson G; Indridason OS; Palsson R; Jonasson F; Jonsdottir I; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Danielsen R; Matthiasson SE; Kristmundsdottir S; Halldorsson BV; Hreidarsson AB; Valdimarsson EM; Gudnason T; Benediktsson R; Steinthorsdottir V; Thorsteinsdottir U; Holm H; Stefansson K
    J Am Coll Cardiol; 2019 Dec; 74(24):2982-2994. PubMed ID: 31865966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers?
    Koschinsky ML
    Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):267-78. PubMed ID: 17378772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.